Global Aging And Genomics Will Unlock Neurodegeneration Breakthroughs
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
11 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$10.00
77.5% undervalued intrinsic discount16 Aug
US$2.25
1Y
-56.2%7D
4.7%